Iveda IVDAW Steady at 004 Awaiting Next Catalyst 20260515 Cocrystal Pharma Files 10Q Quarterly Report Highlighting Clinical Pipeline Progress North NRT Q2 2025 Results Meet Expectations Revenue NA